+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Iron Deficiency Anaemia Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Iron Deficiency Anaemia Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
VONVENDI Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

VONVENDI Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 140 Pages
  • Global
From
Hemophilia Drugs Market Analysis & Forecast 2024-2034: Market By Type; By Treatment; By Therapy; By End-user; and By Region - Product Thumbnail Image

Hemophilia Drugs Market Analysis & Forecast 2024-2034: Market By Type; By Treatment; By Therapy; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Epidemiology Forecast to 2030 - Product Thumbnail Image

Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Epidemiology Forecast to 2030

  • Report
  • April 2021
  • 48 Pages
  • Global
From
Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) - Global Drug Forecast and Market Analysis to 2030

  • Report
  • April 2021
  • 122 Pages
  • Global
From
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 - Product Thumbnail Image

Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

  • Drug Pipelines
  • March 2023
  • 150 Pages
  • Global
From
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 394 Pages
  • Global
From
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 77 Pages
  • Global
From
Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Congenital Fibrinogen Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 53 Pages
  • Global
From
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 182 Pages
  • Global
From
Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 - 2030 - Product Thumbnail Image

Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 - 2030

  • Drug Pipelines
  • December 2021
  • 61 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Hemophilia A and B - Epidemiology Forecast to 2030 - Product Thumbnail Image

Hemophilia A and B - Epidemiology Forecast to 2030

  • Report
  • October 2021
  • 54 Pages
  • Global
From
Chronic Kidney Disease Anemia - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Chronic Kidney Disease Anemia - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 130 Pages
  • Global
From
Hemophilia: Epidemiology Forecast to 2028 - Product Thumbnail Image

Hemophilia: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 48 Pages
  • Global
From
US Hemophilia B Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Hemophilia B Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Myelofibrosis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Myelofibrosis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Iron-Deficiency Anemia Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Iron-Deficiency Anemia Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Thalassemia Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Thalassemia Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Hyperparathyroidism Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Hyperparathyroidism Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more